期刊文献+

生理钙腹透液对尿毒症患者钙磷代谢的影响 被引量:3

下载PDF
导出
出处 《中国中西医结合肾病杂志》 2007年第6期360-361,共2页 Chinese Journal of Integrated Traditional and Western Nephrology
  • 相关文献

参考文献6

  • 1Rahman M,Pressel S,Davis BR,et al.Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.Ann Intern Med,2006,144(3):172-180.
  • 2Athur S,Devaraj S,Jialal I.Accelerated at atherosclrosis,dyslipidemia,and oxidative stress in end-stage renal disease.Curr opin Nephrol Hypertens,2002,11(2):141-147.
  • 3Wang AY,Woo J,Sea MM,et al.Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function:what are the implications?Am J Kidney Dis,2004,43(4):712-720.
  • 4Massry SG,Smogorzewski M.Management of vascular calcificat-ion in CKD patients.Semin Nephrol,2006,26(1):38-41.
  • 5Sanchez C,Lopez-Barea F,Sanchez-Cabezudo J,et al.Low vs standard calcium dialysate in peritoneal dialysis:differences in treatment,biochemistry and bone histomorphometry.A randomized multicentre study.Nephrol Dial Transplant,2004,19(6):1587-1593.
  • 6Terawaki H,Kasai K,Kawaguchi Y,et al.The impact of low calcium dialysate (1.25 mmol/L; LCD) on bone metabolism in CAPD patients.Nippon Jinzo Gakkai Shi,1998,40(4):252-257.

同被引文献25

  • 1林爱武,钱家麒,庞慧华,姚强,俞赞喆,顾爱萍,张凤棣.长期使用低钙透析液对腹膜透析患者钙磷代谢的影响[J].中华肾脏病杂志,2005,21(12):713-715. 被引量:25
  • 2梁馨苓,史伟,章斌,刘双信,林秋雄,黄美萍,王文健,叶智明,何朝生.终末期肾病患者心血管事件与血清胎球蛋白A及冠脉钙化的关系[J].中华肾脏病杂志,2006,22(6):336-340. 被引量:25
  • 3Foley RN,Parfrey PS,Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32(5 Suppl 3):S112-119.
  • 4London GM,Guérin AP,Marchais SJ,et al.Arterial media calcification in end-stage renal disease:impact on all-cause and cardiovascular mortality.Nephrol Dial Transplant,2003,18:1731-1740.
  • 5Wang AY,Wang M,Woo J,et al.Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients:a prospective study.J Am Soc Nephrol,2003,14:159-168.
  • 6Wang AY,Woo J,Lam CW,et al.Associations of serum fetuinA with malnutrition,inflammation,atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.Nephrol Dial Transplant,2005,20:1676-1685.
  • 7Massry SG,Smogorzewski M.Management of vascular calcification in CKD patients.Semin Nephrol,2006,26:38-41.
  • 8Schafer C,Heiss A,Schwarz A,et al.The serum protein alpha 2-Heremans-Schmid glycoproteir/fetuin-A is a systemically acting inhibitor of ectopic calcification.J Clin Invest,2003,112:357-366.
  • 9de Groot E,van Leuven SI,Duivenvoorden R,et al.Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis.Nat Clin Pract Cardiovasc Med,2008,5:280-288.
  • 10O' Leary DH,Polak JF,Kronmal RA,et al.Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study.The CHS Collaborative Research Group.Stroke,1992,23:1752-1760.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部